Detection of transforming growth factor-α in the serum of gastric carcinoma patients

Oncology

Volumn 57, Issue 3, 1999, Pages 236-241

  Choi, Jin Hyuk ^a   Kim, Hugh Chul ^a   Ho Yeong, Lim ^a   Nam, Dong Ki ^a   Kim, Hyun Soo ^a   Yi, Sun Young ^b   Shim, Kang Sup ^b   Han, Woon Sup ^b  

^a Ajou University School of Medicine   (South Korea)

^b Ewha Womans University School of Medicine   (South Korea)

Author keywords

Enzyme linked immunosorbent assay; Gastric carcinoma; Serum; Transforming growth factor

Indexed keywords

TRANSFORMING GROWTH FACTOR ALPHA; TUMOR MARKER;

ADULT; AGED; ANALYTICAL EQUIPMENT; ARTICLE; BLOOD LEVEL; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; MALE; PRIORITY JOURNAL; STOMACH CARCINOMA;

ADULT; AGED; CASE-CONTROL STUDIES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOPLASM STAGING; STOMACH NEOPLASMS; TRANSFORMING GROWTH FACTOR ALPHA; TUMOR MARKERS, BIOLOGICAL;

EID: 0032821512     PISSN: 00302414     EISSN: None     Source Type: Journal    
DOI: 10.1159/000012037     Document Type: Article

References (27)

1. Todaro GJ, Fryling C, De Larco JE: Transforming growth factors produced by certain human tumor cells: Polypeptides that interact with epidermal growth factor receptors. Proc Natl Acad Sci USA 1980;77:5258-5262.
2. Derynck R: Transforming growth factor alpha. Cell 1988;54:593-595.
3. Stemmermann G, Heffelfinger SC, Noffsinger A, Hui YZ, Miller MA, Fenoglio-Preiser CM: The molecular biology of espohageal and gastric cancer and their precursors: Oncogenes, tumor suppressor genes, and growth factors. Hum Pathol 1994;25:968-981.
4. Liu C, Woo A, Tsao M-S: Expression of transforming growth factor-alpha in primary human colon and lung carcinomas. Br J Cancer 1990; 62:425-429.
5. Schreiber AB, Winkler ME, Derynck R: Transforming growth factor-alpha: A more potent angiogenic mediator than epidermal growth factor. Science 1986;232:1250-1253.
6. Pecur L, Kapitanovic S, Sonicki Z, Pavicic F, Spaventi S, Gluckman JL, Stambrook PJ, Pavelic ZP, Spaventi R, Pavelic K: Prognostic significance of transforming growth factor alpha (TGF-α) in human lung carcinoma: An immunohistochemical study. Anticancer Res 1994; 14:2839-2844.
7. Gorgoulis V, Aninos D, Mikou P, Kanavaros P, Karameris A, Joardanoglou J, Rasidakis A, Veslemes M, Ozanne B, Spandidos DA: Expression of EGF, TGF-α and EGFR in squamous cell lung carcinomas. Anticancer Res 1992;12:1183-1188.
8. Tateishi M, Ishida T, Mitsudomi T, Sugimachi K: Prognostic implication of transforming growth factor-α in adenocarcinoma of the lung - An immunohistochemical study. Br J Cancer 1991;63:130-133.
9. Issing WJ, Liebich C, Wustrow TP, Ullrich A: Coexpression of epidermal growth factor receptor and TGF-α and survival in upper aerodigestive tract cancer. Anticancer Res 1996;16:283-288.
10. Younes M, Fernandez L, Lechago J: Transforming growth factor alpha (TGF-alpha) expression in biopsies of colorectal carcinoma is a significant prognostic indicator. Anticancer Res 1996;16:1999-2003.
11. Niikura H, Sasano H, Sato S, Yajima A: Expression of epidermal growth factor-related proteins and epidermal growth factor receptor in common epithelial ovarian tumors. Int J Gynecol Pathol 1997;16:60-68.
12. Yonemura Y, Takamura H, Ninomiya I, Fushida S, Tsugawa K, Kaji M, Nakai Y, Ohoyama S, Yamaguchi A, Miyazaki I: Interrelationship between transforming growth factor-α and epidermal growth factor receptor in advanced gastric cancer. Oncology 1992;49:157-161.
13. c-erbB-2. Oncology 1995;52:385-391.
14. Schwartz GK, Klimstra D, Huang Y, Karpeh M, Tahara E, Kelsen DK: Overexpression of transforming growth factor α (TGF α) in early stage gastric cancer is associated with a worse prognosis in American but not in Japanese patients. Proc Am Soc Clin Oncol 1997;16: 257a.
15. Partanen R, Koskinen H, Oksa P, Hemminki K, Carney W, Smith S, Brandt-Rauf P: Serum oncoproteins in asbestosis patients. Clin Chem 1995;41:1844-1847.
16. Tomiya T, Fujiwara K: Serum levels of transforming growth factor-α in patients after partial hepatectomy as determined with an enzyme-linked immunosorbent assay. Hepatology 1993;18:304-308.
17. Chien C-H, Huang C-C, Lin Y-H, Shen J, Chow S-N: Detection of serum transforming growth factor-α in patients of primary epithelial ovarian cancers by enzyme immunoassay. Gynecol Oncol 1997;66:405-410.
18. Shim K-S, Kim K-H, Park B-W, Yi S-Y, Choi J-H, Han W-S, Park E-B: Increased serum levels of transforming growth factor-α in patients with colorectal cancer. Dis Colon Rectum 1998;41:219-224.
19. Choi J-H, Oh JY, Ryu SK, Kim SJ, Lee NY, Kim YS, Yi SY, Shim KS, Han WS: Detection of epidermal growth factor receptor in the serum of gastric carcinoma patients. Cancer 1997;79:1879-1883.
20. Kim IS, Suh I, Oh HC, Kim BS, Lee Y: Incidence and survival of cancer in Kangwha County (1983-1987). Yonsei Med J 1989;30: 256-268.
21. American Joint Committee on Cancer: Manual for Staging of Cancer, ed 4. Philadelphia, Lippincott, 1992, pp 63-67.
22. Osaki T, Mitsudomi T, Oyama T, Nakanishi R, Yasumoto K: Serum level and tissue expression of c-erbB-2 protein in lung adenocarcinoma. Chest 1995;108:157-162.
23. Moskal TL, Huang S, Ellis LM, Fritsche HA Jr, Chakrabarty S: Serum levels of transforming growth factor α in gastrointestinal cancer patients. Cancer Epidemiol Biomarkers Prev 1995;4:127-131.
24. Isola JJ, Holli K, Oksa H, Teramoto Y, Kallioniemi O-P: Elevated erbB-2 oncoprotein levels in preoperative and follow-up serum samples define an aggressive disease course in patients with breast cancer. Cancer 1994;73:652-658.
25. Kandl H, Seymour L, Bezwoda WR: Soluble c-erbB-2 fragment in serum correlates with disease stage and predicts for shortened survival in patients with early-stage and advanced breast cancer. Br J Cancer 1994;70:739-742.
26. neu in human ovarian cancer. Cancer 1993;71:3942-3946.
27. Okada N, Ohshio G, Yamaki K-I, Imamura T, Imamura M: Elevated serum c-erbB-2 protein levels in patients with pancreatic cancer: Correlation to metastasis and shorter survival. Oncology 1995;52:392-396.